Answer
Pegvisomant (Somavert) is administered by subcutaneous injection, initially as an 80 mg loading dose under medical supervision, followed by 10 mg once daily with subsequent dose adjustments based on serum IGF-I levels, rotating injection sites daily to help prevent lipohypertrophy.
Sources for this answer
- SOMAVERT 10mg powder and solvent for solution for injectionPfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 26Document updated
Sources checked